Celon Pharma Capital Markets Day

4 komentrzy na “Celon Pharma Capital Markets Day”

1. Robin Jan on April 21st, 2021 - 2:21pm

   Does it make sense for company of that size to concentrate on such different areas instead of stick with one or two?

2. Edward Kahn on April 21st, 2021 - 2:23pm

   Bravo for work in Ketamine in dry powdered Inhaler.

   Know how in inhalant powder delivery (no cash required) can generate Celon dominant position in COPD. First real curative treatment for COPD.

   Ed Kahn
   617 834 3863

3. Wojciech Knap on April 21st, 2021 - 4:09pm

   Why Spravato is not gaining market share as expected? Is it true that it is last line of tratment?

4. Dorota on April 21st, 2021 - 4:47pm

   Congratulations 🙂